SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:uu-499057"
 

Sökning: id:"swepub:oai:DiVA.org:uu-499057" > Synthesis and evalu...

Synthesis and evaluation of fluorine-18 labelled tetrazines as pre-targeting imaging agents for PET

Schlein, Eva (författare)
Uppsala universitet,Geriatrik,Molecular Geriatrics
Rokka, Johanna (författare)
Uppsala universitet,Geriatrik,Molecular Geriatrics
Odell, Luke R. (författare)
Uppsala universitet,Preparativ läkemedelskemi
visa fler...
Lopes van den Broek, Sara (författare)
Uppsala universitet,Geriatrik,Molecular Geriatrics
Herth, Matthias M. (författare)
Department of Drug Design and Pharmacology, University of Copenhagen
Battisti, Umberto M. (författare)
Department of Drug Design and Pharmacology, University of Copenhagen
Syvänen, Stina (författare)
Uppsala universitet,Geriatrik,Molecular Geriatrics
Sehlin, Dag, 1976- (författare)
Uppsala universitet,Geriatrik,Molecular Geriatrics
Eriksson, Jonas (författare)
Uppsala universitet,Preparativ läkemedelskemi,PET Centre, Uppsala University Hospital
visa färre...
 (creator_code:org_t)
Springer Nature, 2024
2024
Engelska.
Ingår i: EJNMMI Radiopharmacy and Chemistry. - : Springer Nature. - 2365-421X. ; 9:1
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • The brain is a challenging target for antibody-based positron emission tomography (immunoPET) imaging due to the restricted access of antibody-based ligands through the blood-brain barrier (BBB). To overcome this challenge we have previously developed bispecific antibody ligands that pass through the BBB via receptor-mediated transcytosis. These ligands, when radiolabelled, can be used for brain imaging with high affinity and specificity, but their long residence time in the blood and brain can be challenging for their use as PET radioligands. This could be solved by using a two-step approach which involves the administration of a tagged antibody that accumulates at the target site in the brain and then clears from the blood, followed by administration of a radiolabelled molecule, with fast kinetics. This radiolabelled molecule can couple to the tagged antibody and thereby make the antibody localisation visible by PET imaging. The in vivo linkage can be achieved using the inverse electron demand Diels-Alder reaction (IEDDA), with trans-cyclooctene (TCO) and tetrazine groups participating as reactants.In this study, two 18F-labelled tetrazines were synthesized and evaluated for their potential as agents for pre-targeted imaging, i.e. for their ability to rapidly enter the brain and then, if non-bound, be sufficiently cleared with low background retention. The two compounds, a methyl tetrazine [18F]MeTz and an H-tetrazine [18F]HTz were radiolabelled using a two-step procedure via [18F]F-Py-TFP synthesized on solid support followed by amidation with amine-bearing tetrazines, resulting in radiochemical yields of 24% and 22%, respectively, and a radiochemical purity of > 96%. In vivo PET imaging was performed to assess their suitability for in vivo pre-targeting. Time-activity curves from PET-scans revealed that the [18F]MeTz had the most favourable profile for an imaging agent for pre-targeting, due to its fast and homogenous brain distribution and rapid clearance from the brain.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Radiologi och bildbehandling (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Radiology, Nuclear Medicine and Medical Imaging (hsv//eng)

Nyckelord

Inverse electron demand Diels−Alder reaction IEDDA
pre-targeting
tetrazine
Alzheimer’s disease
bio-orthogonal
Fluorine-18

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy